Uprosertib, Dabrafenib, and Trametinib in Treating Patients With Stage IIIC-IV Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Antoni Ribas
SWOG Cancer Research Network
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ucla / Jonsson Comprehensive Cancer Center
Los Angeles, California, United States
- Usc / Norris Comprehensive Cancer Center
Los Angeles, California, United States
- California Pacific Medical Center-Pacific Campus
San Francisco, California, United States
- Ucsf Medical Center-Mount Zion
San Francisco, California, United States
- Uchealth University of Colorado Hospital
Aurora, Colorado, United States
- University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, United States
- Cleveland Clinic Foundation
Cleveland, Ohio, United States
- Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
- Clackamas Radiation Oncology Center
Clackamas, Oregon, United States
- Providence Milwaukie Hospital
Milwaukie, Oregon, United States
- Providence Newberg Medical Center
Newberg, Oregon, United States
- Providence Willamette Falls Medical Center
Oregon City, Oregon, United States
- Oregon Health and Science University
Portland, Oregon, United States
- Providence Portland Medical Center
Portland, Oregon, United States
- Providence Saint Vincent Medical Center
Portland, Oregon, United States
- Peacehealth Southwest Medical Center
Vancouver, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 8 Oct 2013
- Primary completion
- 16 May 2018
- Completion
- 23 Dec 2023
- Last update posted
- 14 Jan 2025
- Registered enrollment
- 27
- Registry id
- NCT01902173
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.